---
layout: minimal-medicine
title: Sipuleucel-T
---

# Sipuleucel-T
### Generic Name
Sipuleucel-T

### Usage
Sipuleucel-T is a type of immunotherapy used to treat asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer.  This means it's used in men with prostate cancer that has spread to other parts of the body, and whose cancer hasn't responded to hormone therapy.  It's specifically for men who aren't experiencing significant symptoms from their cancer.  Sipuleucel-T is not a first-line treatment for prostate cancer.

### Dosage

**Adult Dosage (Prostate Cancer):** Sipuleucel-T is administered intravenously (IV).  The recommended dosage is a minimum of 50 million autologous CD54+ cells (these cells are collected from the patient's own blood through a process called leukapheresis and then activated in the lab) in each dose.  Three doses are given, typically about two weeks apart (although the interval can range from one to fifteen weeks).  

* **Premedication:** Before each infusion, patients are usually premedicated with acetaminophen (650mg) and an antihistamine (such as diphenhydramine 50mg) about 30 minutes prior to reduce the risk of side effects.
* **Infusion Rate:** The infusion is given over approximately 60 minutes. A cell filter should not be used.
* **Missed Doses:** If a scheduled infusion is missed, another leukapheresis procedure is needed before treatment can continue.

**Pediatric Dosage:** Sipuleucel-T is not approved for use in children.

**Dosage Adjustments:**  The manufacturer's labeling doesn't provide dosage adjustments for hepatic (liver) or renal (kidney) impairment.  Management of toxicity, such as acute infusion reactions, may involve interrupting or slowing the infusion rate, and using medications like acetaminophen, antihistamines, or low-dose meperidine to control symptoms.

### Side Effects

**Common Side Effects (>10%):**

* Chills
* Fatigue
* Headache
* Dizziness
* Pain
* Nausea
* Vomiting
* Constipation
* Anemia


**Less Common, but Potentially Serious Side Effects (1-10% or less):**

* Hypertension
* Hemorrhagic stroke (bleeding in the brain)
* Ischemic stroke (blocked blood flow to the brain)
* Flu-like symptoms
* Dyspnea (shortness of breath)
* Skin rash
* Anorexia (loss of appetite)
* Musculoskeletal pain
* Muscle spasms
* Hematuria (blood in the urine)


**Rare Side Effects (<1% or post-marketing reports):**

* Cerebrovascular accident (stroke)
* Eosinophilia (increased eosinophils, a type of white blood cell)
* Hypotension (low blood pressure)
* Myasthenia gravis (muscle weakness)
* Myocardial infarction (heart attack)
* Myositis (muscle inflammation)
* Paresthesia (numbness or tingling)
* Pulmonary embolism (blood clot in the lung)
* Rhabdomyolysis (muscle breakdown)
* Sepsis (life-threatening infection)
* Syncope (fainting)
* Transient ischemic attacks (mini-strokes)
* Tumor flare (worsening of cancer symptoms)
* Venous thrombosis (blood clot in a vein)


If you experience any concerning side effects, contact your healthcare provider immediately.


### How it Works

Sipuleucel-T is a form of cellular immunotherapy.  It uses the patient's own immune cells (specifically antigen-presenting cells or APCs).  These cells are collected, then activated in a lab with a protein called PAP-GM-CSF. This protein combines prostatic acid phosphatase (PAP), an antigen often found on prostate cancer cells, with granulocyte-macrophage colony-stimulating factor (GM-CSF), which helps activate the immune system.  Once infused back into the patient, these activated cells help the immune system recognize and attack prostate cancer cells.

### Precautions

* **Immunosuppressants:**  Immunosuppressant medications may decrease the effectiveness of Sipuleucel-T.  Healthcare providers should carefully assess the need to adjust or stop immunosuppressants before starting Sipuleucel-T.
* **Thromboembolic Events:**  There's an increased risk of blood clots (thromboembolic events) with Sipuleucel-T.  It should be used cautiously in patients already at high risk for these events.
* **Cerebrovascular and Cardiovascular Events:**  Sipuleucel-T has been associated with an increased risk of strokes and heart attacks. Close monitoring is essential, particularly in patients with pre-existing heart or blood vessel conditions.
* **Infusion Reactions:** Acute reactions during infusion can occur.  Patients should be monitored closely.
* **Pregnancy and Lactation:** Sipuleucel-T is not recommended for women who are pregnant or breastfeeding.

### FAQs

* **Q: How long does treatment with Sipuleucel-T last?** A:  The treatment course typically involves three infusions given over several weeks.

* **Q: How is Sipuleucel-T stored?** A:  The medication requires specific storage and handling instructions provided by the manufacturer and healthcare provider.  It should be kept in the insulated container provided until immediately before administration.

* **Q: Are there any specific dietary restrictions during treatment?** A:  There are usually no specific dietary restrictions, but it's always best to consult your healthcare provider for personalized advice.

* **Q: What should I do if I miss a dose?** A: Contact your doctor immediately; a new leukapheresis procedure will be required.

* **Q: Is Sipuleucel-T a cure for prostate cancer?** A: Sipuleucel-T is not a cure, but it may help extend survival and improve quality of life in some patients.  The effectiveness varies from person to person.  It's crucial to discuss treatment options and expectations with your healthcare team.


**Disclaimer:** This information is intended for general knowledge and informational purposes only, and does not constitute medical advice.  Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized advice based on your specific medical history and condition.
